Chat with Enda
πŸ“ž +27 74 337 2721  |  βœ‰οΈ endamari100@gmail.com πŸ‡ΏπŸ‡¦ South Africa  β€’  glp1peptides.co.za

HD TIRSEMA 44 MG PEN

R 2600

 

HD Labs – Ozempic/Tirzepatide Hybrid – Trisema Pen 44mg

Semaglutide/Tirzepatide – Treat 2 diabetes and long-term weight management

 

Description

Trisema 44mg Pre Filled Pen is a cutting-edge injectable weight management compound combining two synergistic peptides in one formulation. Designed for once-weekly use, it delivers comprehensive metabolic support through improved blood glucose control, increased insulin sensitivity, and significant appetite suppression. The unique mechanism of action helps users feel fuller for longer, reduce caloric intake effortlessly, and enhance fat-burning potential while preserving lean muscle.

 

Ideal for individuals struggling with weight plateaus, insulin resistance, or persistent cravings, Trisema 44mg Pre Filled Pen is highly effective when paired with healthy nutrition and a consistent fitness routine. Its convenient pen delivery makes it easy to administer precise weekly doses with minimal hassle.

 

Benefits

Dramatically reduces appetite and food cravings

Supports rapid and sustained fat loss

Enhances insulin sensitivity and metabolic control

Slows gastric emptying for prolonged fullness

Aids body recomposition when paired with training

 

Easy-to-use weekly injection with click-based dosing

 

Side effects

Nausea, especially during dose increases

Mild gastrointestinal discomfort (bloating, constipation)

Headaches or fatigue

Possible dizziness

Injection site irritation

Loss of appetite (intentional, but may feel intense)

 

Dosages & Protocol

Dosing is administered in clicks on the pen. Titrate weekly as your body adjusts to the compound.

 

Suggested protocol – ONCE WEEKLY:

 

Week 1 – 4: 15 clicks (once weekly)

 

Week 5-8: 30 clicks

 

Week 9-12: 45 clicks

 

Week 13-16: 60 clicks

 

Cycle length: 12 to 24 weeks for optimal results

 

How to administer

Trisema 44mg Pre Filled Pen is injected subcutaneously once per week using the included pen and needles.

 

Steps:

Remove the cap and attach a new needle

Clean the injection site (abdomen or thigh)

Turn the dose dial to the correct number of clicks

Pinch the skin and insert needle at a 90Β° angle

Press the injection button and hold for 5–10 seconds

Remove the pen, dispose of the needle safely

Recap and store the pen in the fridge

Use a new needle for each injection. Rotate injection sites weekly.

 

Storage

Store refrigerated at 2–8Β°C

Do not freeze

Keep capped when not in use

 

Pen remains viable for up to 30 days after first use if refrigerated properly

HD MOTS-C 10MG VIAL

R 900

 

MOTS-C 10mg – HD Laboratories

MOTS-C is a mitochondrial-derived peptide (MDP) researched for its role in cellular energy regulation and metabolic signaling. Naturally encoded within mitochondrial DNA, MOTS-C functions as a metabolic messenger that helps regulate stress adaptation, glucose utilization, and mitochondrial efficiency.

 

The 10mg vial by HD Laboratories contains high-purity lyophilized MOTS-C intended for laboratory and research applications.

 

Mechanism of Action

MOTS-C is classified as a mitochondrial β€œmitokine” and primarily exerts its effects through metabolic signaling pathways:

AMPK Activation – Stimulates AMP-activated protein kinase, a key cellular energy sensor.

Enhanced Glucose Uptake – May promote improved glucose utilization at the cellular level.

Fatty Acid Oxidation Support – Encourages metabolic flexibility.

Nuclear Gene Regulation – Influences transcription factors associated with stress adaptation and metabolic balance.

Mitochondrial Efficiency – Supports cellular resilience under metabolic stress conditions.

Its mechanism makes it a peptide of interest in research related to metabolic health, body composition, endurance performance, and longevity pathways.

 

Potential Research Applications

While human clinical data remains limited, MOTS-C is commonly explored in research contexts for:

Metabolic optimization

Insulin sensitivity support

Body composition improvement

Exercise endurance and recovery

Healthy aging and mitochondrial support

All applications remain investigational.

 

Recommended Research Dosing Protocols

⚠ There are no FDA-approved or clinically established human dosing guidelines for MOTS-C. The following reflects commonly observed research practices and community protocols.

 

General Administration

Route: Subcutaneous (SC) injection

Typical Dose Range: 5–10mg per administration

Frequency: 2–3 times per week

Cycle Duration: 4–12 weeks

Break Period: 4–8 weeks off between cycles

 

Storage: Refrigerate at 2–8Β°C after reconstitution

 

Goal-Specific Protocol Examples

1. Metabolic Optimization

Dose: 5–10mg

Frequency: 2–3Γ— weekly

Timing: Morning or before meals

Cycle: 8–12 weeks

Intended to align with circadian metabolic signaling and glucose regulation pathways.

2. Body Composition & Fat Oxidation

Dose: ~10mg per week (split into 2–3 injections)

Timing: 30–60 minutes before exercise

Cycle: 8–12 weeks

Often paired with structured nutrition and resistance training protocols.

3. Endurance & Athletic Performance

Dose: 10mg weekly (divided doses)

Timing: 30–60 minutes pre-workout

Cycle: 6–8 weeks

Explored for its interaction with exercise-induced AMPK activation.

4. Longevity & Mitochondrial Research

Dose: 5–10mg weekly

Frequency: 2Γ— weekly

Cycle: 10–12+ weeks

Focuses on mitochondrial stress resilience and metabolic health pathways.

 

Timing Considerations

Morning administration may align with fasting metabolic activity.

Pre-workout dosing is often utilized to synergize with exercise-induced metabolic activation.

Consistency in weekly timing appears more important than exact hour of administration.

 

Administration Guidelines

Reconstitute with bacteriostatic water using sterile technique.

Inject subcutaneously using an insulin syringe.

Rotate injection sites (abdomen, thigh, upper arm).

Do not shake vigorously during reconstitution.

Discard if solution becomes cloudy or discolored.

HD GHK-CU 100MG VIAL

R1250

 

GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper) is a naturally occurring copper-binding peptide found in human plasma, saliva, and urine. It plays a vital role in tissue remodeling, collagen synthesis, and cellular repair. When levels decline with age, skin elasticity and regenerative capacity decrease β€” supplementing with GHK-Cu helps restore these functions. This peptide enhances fibroblast activity, promotes angiogenesis, and stimulates the synthesis of key extracellular matrix components such as collagen and elastin. Its benefits extend beyond cosmetic applications, also supporting wound repair, reducing inflammation, and strengthening hair follicles.

 

Benefits:

 

Stimulates collagen and elastin production for firmer skin

Promotes hair regrowth and scalp health

Accelerates wound healing and tissue regeneration

Reduces inflammation and oxidative stress

Improves skin tone, texture, and elasticity

Supports anti-aging and overall skin rejuvenation

 

Side Effects:

 

Mild skin irritation or redness at injection site

 

Temporary sensitivity or tingling sensation

 

Rare allergic reaction in sensitive individuals

 

Dosages & Protocol:

Beginners: 2mg injected subcutaneously once daily

Intermediate: 2mg injected twice daily (morning and evening)

Advanced: 2–4mg injected twice daily or applied topically for targeted repair

 

HD CAGRILINTIDE 10MG VIAL

R 1950

 

What Is Cagrilintide?

 

πŸ”₯ Why It’s So Powerful

Cagrilintide is being developed mainly to be combined with Semaglutide (the combo is called CagriSema).

Studies show:

 

πŸ’ͺ Benefits

HD SEMAGLUTIDE 10MG PEN

R2100

 

Introduction

Semaglutide 10mg is an advanced medication designed for weight management and diabetes control.

How It Works

Semaglutide works by mimicking a hormone that targets areas of the brain involved in appetite regulation.

Benefits

Usage

Primarily prescribed for managing type 2 diabetes and assisting in weight loss.

Recommended Dosage

Conclusion

Semaglutide 10mg offers a dual benefit of diabetes control and weight reduction, making it a valuable treatment option.

HD SEMAGLUTIDE 10MG VIAL

R1600

 

Introduction

Semaglutide 10mg is an advanced medication designed for weight management and diabetes control.

 

How It Works

Semaglutide works by mimicking a hormone that targets areas of the brain involved in appetite regulation.

 

Benefits

Enhances blood sugar control in type 2 diabetes patients.

Promotes significant weight loss.

Reduces risk factors associated with heart disease.

Usage

Primarily prescribed for managing type 2 diabetes and assisting in weight loss.

 

Recommended Dosage

Start with 0.25 mg once weekly.

Gradually increase to the effective dose of 6mg based on response and tolerability.

Conclusion

Semaglutide 10mg offers a dual benefit of diabetes control and weight reduction, making it a valuable treatment option.

 

HD TIRZEPATIDE 30MG PEN

R 2600

 

Properties and Mechanism of Action


HD Labs Tirzepatide is a dual-agonist peptide that works by activating two key metabolic pathways:

GLP-1 receptor activation – promotes appetite suppression and improved satiety

GIP receptor activation – supports insulin sensitivity and efficient energy utilization

Supports metabolic balance – aids fat metabolism and overall metabolic function

Effects and Results
Reduced appetite and cravings
Increased feelings of fullness and improved portion control
Enhanced fat metabolism and energy regulation
Support for healthy blood sugar levels and overall metabolic function
Results may vary depending on individual lifestyle, diet and exercise.

The HD Labs Tirzepatide Vial is administered via subcutaneous injection, typically once weekly.

Recommended guidance includes:
Start with a low initial dose to support tolerability
Gradual dose escalation over several weeks
Maintain consistent weekly administration for best results

Possible Side Effects
Some individuals may experience mild to moderate side effects, particularly during dose escalation:

Nausea
Reduced appetite
Gastrointestinal discomfort (bloating, constipation, diarrhea)
Fatigue
Headache

Side effects are generally temporary and tend to subside as the body adjusts.

 

HD TIRZEPATIDE 30MG VIAL

R 2000

 

The HD Labs Tirzepatide Vial 30mg is a premium dual-agonist peptide therapy designed for advanced weight management, appetite control and metabolic optimization. Developed and formulated by HD Labs, this vial contains 30mg of Tirzepatide in a convenient format suitable for structured wellness and weight-loss programs. Tirzepatide targets both GLP-1 and GIP receptors, helping reduce cravings, improve satiety and enhance metabolic efficiency.

 

Properties and Mechanism of Action

HD Labs Tirzepatide is a dual-agonist peptide that works by activating two key metabolic pathways:

 

GLP-1 receptor activation – promotes appetite suppression and improved satiety

 

GIP receptor activation – supports insulin sensitivity and efficient energy utilization

 

Supports metabolic balance – aids fat metabolism and overall metabolic function

 

Effects and Results

Reduced appetite and cravings

Increased feelings of fullness and improved portion control

Enhanced fat metabolism and energy regulation

Support for healthy blood sugar levels and overall metabolic function

Results may vary depending on individual lifestyle, diet and exercise.

 

The HD Labs Tirzepatide Vial is administered via subcutaneous injection, typically once weekly.

 

Recommended guidance includes:

Start with a low initial dose to support tolerability

Gradual dose escalation over several weeks

Maintain consistent weekly administration for best results

 

Possible Side Effects

Some individuals may experience mild to moderate side effects, particularly during dose escalation:

 

Nausea

Reduced appetite

Gastrointestinal discomfort (bloating, constipation, diarrhea)

Fatigue

Headache

 

Side effects are generally temporary and tend to subside as the body adjusts.

 

 

 

 

HD RETATRUTIDE 32MG PENΒ 

R 2950

 

Premium High-Concentration Metabolic Therapy

HD Labs Retatrutide 32mg delivers an advanced, high-concentration formulation of this breakthrough triple-agonist peptide. Designed for experienced users seeking maximum efficacy, this pharmaceutical-grade vial provides enhanced dosing flexibility for comprehensive metabolic support and weight management goals.

 

Clinical Profile

Retatrutide represents the cutting edge in peptide-based metabolic therapy, simultaneously targeting GIP, GLP-1, and glucagon receptors. This triple-receptor mechanism provides comprehensive metabolic pathway activation, offering superior support for individuals committed to evidence-based weight management and body composition optimization.

 

Key Benefits

High-concentration 32mg formulation for extended treatment protocols

Triple-receptor agonist mechanism (GIP, GLP-1, glucagon)

Multi-pathway metabolic activation

Supports comprehensive weight management objectives

Promotes optimal body composition outcomes

Pharmaceutical-grade manufacturing standards

Enhanced dosing flexibility and cost-effectiveness.

Concentration: 32mg per vial

Form: Lyophilized powder for reconstitution

Manufacturer: HD Labs

Storage: Refrigerate at 2-8Β°C before and after reconstitution

 

Administration Guidelines

This product requires reconstitution with bacteriostatic water prior to subcutaneous administration. Due to the high concentration, precise dosing protocols must be established and monitored by a qualified healthcare professional with expertise in peptide therapy. Proper reconstitution technique and sterile handling are essential.

 

Quality Assurance

HD Labs maintains rigorous pharmaceutical manufacturing standards with comprehensive quality control testing for purity, potency, and sterility. Each vial includes complete batch traceability and certificate of analysis documentation.

 

Important: This product is intended for use under medical supervision by experienced individuals. Consult with a qualified healthcare provider before beginning any peptide therapy program. Not intended for use by individuals under 18 years of age or those new to peptide therapy.

 

 

 

HD RETATRUTIDE 32MG VIAL – R2500

 

Premium High-Concentration Metabolic Therapy

HD Labs Retatrutide 32mg delivers an advanced, high-concentration formulation of this breakthrough triple-agonist peptide. Designed for experienced users seeking maximum efficacy, this pharmaceutical-grade vial provides enhanced dosing flexibility for comprehensive metabolic support and weight management goals.

 

Clinical Profile

Retatrutide represents the cutting edge in peptide-based metabolic therapy, simultaneously targeting GIP, GLP-1, and glucagon receptors. This triple-receptor mechanism provides comprehensive metabolic pathway activation, offering superior support for individuals committed to evidence-based weight management and body composition optimization.

 

Key Benefits

High-concentration 32mg formulation for extended treatment protocols

Triple-receptor agonist mechanism (GIP, GLP-1, glucagon)

Multi-pathway metabolic activation

Supports comprehensive weight management objectives

Promotes optimal body composition outcomes

Pharmaceutical-grade manufacturing standards

Enhanced dosing flexibility and cost-effectiveness.

Concentration: 32mg per vial

Form: Lyophilized powder for reconstitution

Manufacturer: HD Labs

Storage: Refrigerate at 2-8Β°C before and after reconstitution

 

Administration Guidelines

This product requires reconstitution with bacteriostatic water prior to subcutaneous administration. Due to the high concentration, precise dosing protocols must be established and monitored by a qualified healthcare professional with expertise in peptide therapy. Proper reconstitution technique and sterile handling are essential.

 

Quality Assurance

HD Labs maintains rigorous pharmaceutical manufacturing standards with comprehensive quality control testing for purity, potency, and sterility. Each vial includes complete batch traceability and certificate of analysis documentation.

 

Important: This product is intended for use under medical supervision by experienced individuals. Consult with a qualified healthcare provider before beginning any peptide therapy program. Not intended for use by individuals under 18 years of age or those new to peptide therapy.